{"id":1209333,"title":"DSEN Abstract: Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-15","captureTimestamp":"2026-02-15T15:41:30.801000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53213.html","snippet":"DSEN Abstract Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure Despite low rates of sofosbuvir failure in the pivotal clinical trials (2 - 4%), this real-world trial shows a higher failure rate of 9.5%. This study also found that patients…","rawSnapshotUrl":"/api/snapshots/raw/1209333","browseUrl":"https://replay.healtharchive.ca/job-8/20260215154130/https://cihr-irsc.gc.ca/e/53213.html#ha_snapshot=1209333","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}